新西兰Wellumio公司正在筹集资金,以加速其便携式中风探测装置,该设备可以在几分钟内识别脑损伤。 New Zealand company Wellumio is raising funds to speed up its portable stroke-detecting device, which can identify brain damage in minutes.

位于新西兰的一家医疗技术公司Wellumio正在筹集资金,以加速其便携式Axana神经成像装置,该装置在几分钟内检测到急性中风生物标记,将诊断时间减少90%以上。 Wellumio, a New Zealand-based medical tech company, is raising funds to accelerate its portable Axana® neuroimaging device, which detects acute stroke biomarkers in minutes, reducing diagnosis time by over 90%. 这种轻量级、电池动力装置能够在急诊部门、农村医院和流动单位进行护理点中风检测,支持在关键的“黄金时”及时治疗。 The lightweight, battery-powered device enables point-of-care stroke detection in emergency departments, rural hospitals, and mobile units, supporting timely treatment during the critical "golden hour." Axana利用专利技术,在没有大型非移动设备的情况下提供磁共振质量脑成像。 Using patented technology, Axana delivers MRI-quality brain imaging without large, immobile equipment. 该公司正在通过多中心试验和针对全球中风诊断市场(超过89亿美元)寻求监管批准。 The company is pursuing regulatory approval through multi-center trials and targeting a global stroke diagnostic market exceeding $8.9 billion.